Xiclav 250 mg

Product information

Trade name: Xiclav 250 mg

Active substance: acid clavulanic, amoxicilină trihidrat

Therapeutic group: Antibiotics

Pharmaceutical form: comprimate filmate

Presentation: blister x 8 cpr.

Target species: dogs, cats

Therapeutic action: Caini si pisici Tratamentul infectiilor determinate de microorganisme sensibile la acțiunea substanțelor active.

Waiting period: Nu este cazul.

Release mode: Cu prescripţie

Authorization number: 160256

Authorization status: Retrasa

Date of issue of the authorization: 17-08-2016

Authorization valid until: nelimitata

Manufacturer / Serial Release Company: LEK PHARMACEUTICALS d.d., Slovenia

Licensee: NOVARTIS ANIMAL HEALTH d.o.o., Slovenia

Responsible company in Romania: BIOMEDIAL REGULATORY SRL

Remarks: Autorizatie de Comercializare retrasă din 13.04.2017, la solicitarea deținătorului autorizatiei de comercializare.